| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 677.16B | 715.28B | 717.25B | 628.11B | 539.61B |
| Gross Profit | 255.30B | 293.77B | 296.23B | 277.73B | 225.97B |
| EBITDA | 31.10B | 61.00B | 77.66B | 87.00B | 71.46B |
| Net Income | -86.09B | 6.12B | 32.57B | 44.94B | 42.68B |
Balance Sheet | |||||
| Total Assets | 1.08T | 1.11T | 1.15T | 1.05T | 1.04T |
| Cash, Cash Equivalents and Short-Term Investments | 158.04B | 163.59B | 206.64B | 211.34B | 370.28B |
| Total Debt | 219.96B | 206.54B | 184.10B | 158.10B | 153.10B |
| Total Liabilities | 486.81B | 471.29B | 462.02B | 431.92B | 439.60B |
| Stockholders Equity | 586.78B | 637.98B | 683.79B | 614.97B | 597.68B |
Cash Flow | |||||
| Free Cash Flow | -40.98B | -3.90B | -8.45B | -23.12B | 13.37B |
| Operating Cash Flow | -4.44B | 48.26B | 30.77B | 15.00M | 31.35B |
| Investing Cash Flow | -12.60B | -69.99B | -49.28B | -112.15B | -385.00M |
| Financing Cash Flow | 858.00M | -19.81B | -1.07B | -56.21B | -26.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥168.81B | 14.71 | ― | 3.47% | -4.54% | -15.36% | |
70 Neutral | ¥119.37B | 17.64 | ― | 4.78% | 4.15% | -73.12% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥493.71B | 20.93 | 3.68% | 2.35% | 0.70% | 95.26% | |
52 Neutral | ¥601.10B | -7.22 | 1.29% | 2.88% | -5.33% | -1578.42% |